KRRO-121 — IND submission
H2 2026
KRRO-121 regulatory submission to enable commencement of FIH trial is anticipated in the 2nd half of 2026Source filing
KORRO BIO INC · Data as of 2026-09-08
H2 2026
KRRO-121 regulatory submission to enable commencement of FIH trial is anticipated in the 2nd half of 2026Source filing
H2 2026
Nominate development candidate for a third GalNAc-conjugated program in the second half of 2026Source filing